Credit Suisse’s Mesoblast MESO Stock Holding History

Credit Suisse’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-67,550	Closed	-$535K	–	4194
2016 Q2	$535K	Buy	+67,550	New	+$970K	﹤0.01%	3378

Other funds holding MESO

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCMI

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

OWD

Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Credit Suisse's MESO Position: Q3 2016 in Review

Credit Suisse sold out of Mesoblast (MESO) in Q3 2016, closing a stake of 67,550 shares — an estimated $535K sold.

Credit Suisse first reported a position in MESO in Q2 2016 and held it in 1 quarter. The position peaked at $535K in Q2 2016. 17 funds tracked by Wall St. Rank hold MESO as of Q3 2016.

Credit Suisse reported no remaining Mesoblast position as of Q3 2016 after selling out during the quarter.
Credit Suisse sold 67,550 Mesoblast shares in Q3 2016, an estimated $535K.
Credit Suisse first reported a position in Mesoblast in Q2 2016 and held it in 1 quarter.
Credit Suisse's Mesoblast position peaked at $535K in Q2 2016.
17 funds tracked by Wall St. Rank held Mesoblast as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.